Mark Manning
91Patents
23h-index
49Co-inventors
88Inventor score
Filing activity: Apr 10, 1978 → Sep 4, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6613358B2 | Sustained-release composition including amorphous polymer | Human Necessities | 150 | Expired |
| US5981474A | Solubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the same | Emerging Cross-Sectional Technologies | 124 | Expired |
| US5770559A | Solubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the same | Emerging Cross-Sectional Technologies | 121 | Expired |
| US5861174A | Temperature sensitive gel for sustained delivery of protein drugs | Human Necessities | 54 | Expired |
| US9382317B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 45 | Active |
| US6482435B1 | Temperature sensitive gel for sustained delivery of protein drugs | Human Necessities | 45 | Expired |
| US9346880B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 40 | Active |
| US9340611B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 40 | Active |
| US9340612B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 40 | Active |
| US5666900A | Method and apparatus for deploying an expendable autonomous underwater vehicle from a submarine | Mechanical Engineering; Lighting; Heating | 34 | Expired |
| US9861695B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 31 | Active |
| US9782480B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 24 | Active |
| US9731008B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 24 | Active |
| US9707293B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 24 | Active |
| US9770507B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 24 | Active |
| US9731009B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 24 | Active |
| US9808525B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 24 | Active |
| US9737600B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 24 | Active |
| US9724415B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 24 | Active |
| US9724414B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 23 | Active |
| US9782479B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 23 | Active |
| US9789185B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 23 | Active |
| US9757454B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 23 | Active |
| US9682145B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 23 | Active |
| US10155039B2 | Stable aqueous formulations of adalimumab | Chemistry; Metallurgy | 20 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.